Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Andriessen

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
Journal of Clinical Pharmacology|May 17, 2019
Recently Registered Midazolam Doses for Preterm Neonates Do Not Lead to Equal Exposure: A Population Pharmacokinetic ModelSwantje Völler, Robert B Flint, Fouzi Beggah, et al.
British Journal of Clinical Pharmacology|April 7, 2020
Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosusAline G J Engbers, Robert B Flint, Swantje Völler, et al.
Children (Basel, Switzerland)|October 28, 2023
Opportunities and Challenges of Prognostic Models for Extremely Preterm InfantsAngret de Boer, Pauline E van Beek, Peter Andriessen, et al.
Plos One|August 31, 2013
Mesenchymal stem cells induce T-cell tolerance and protect the preterm brain after global hypoxia-ischemiaReint K Jellema, Tim G A M Wolfs, Valéria Lima Passos, et al.
Pediatric Research|July 23, 2020
The bioavailability and maturing clearance of doxapram in preterm infantsRobert B Flint, Sinno H P Simons, Peter Andriessen, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|April 30, 2025
Stakeholder Perspectives on the Design of First-In-Human Trials for Artificial Amnion and Placenta Technology: A Qualitative StudyAngret de Boer, André Krom, Rania Kalaai, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|March 3, 2022
Two-year neurodevelopmental outcome in children born extremely preterm: the EPI-DAF studyPauline E van Beek, Monique Rijken, Lisa Broeders, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|December 10, 2023
Neurodevelopmental outcome at 5.5 years in Dutch preterm infants born at 24-26 weeks' gestational age: the EPI-DAF studyPauline E van Beek, Monique Rijken, Lisa Broeders, et al.
Plos One|October 17, 2012
A clinical prediction rule for histological chorioamnionitis in preterm newbornsJasper V Been, Sizzle F Vanterpool, Jasmijn D E de Rooij, et al.
Experimental Neurology|October 15, 2013
Systemic G-CSF attenuates cerebral inflammation and hypomyelination but does not reduce seizure burden in preterm sheep exposed to global hypoxia-ischemiaReint K Jellema, Valéria Lima Passos, Daan R M G Ophelders, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Journal of Clinical Pharmacology|May 17, 2019
Recently Registered Midazolam Doses for Preterm Neonates Do Not Lead to Equal Exposure: A Population Pharmacokinetic ModelSwantje Völler, Robert B Flint, Fouzi Beggah, et al.
British Journal of Clinical Pharmacology|April 7, 2020
Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosusAline G J Engbers, Robert B Flint, Swantje Völler, et al.
Children (Basel, Switzerland)|October 28, 2023
Opportunities and Challenges of Prognostic Models for Extremely Preterm InfantsAngret de Boer, Pauline E van Beek, Peter Andriessen, et al.
Plos One|August 31, 2013
Mesenchymal stem cells induce T-cell tolerance and protect the preterm brain after global hypoxia-ischemiaReint K Jellema, Tim G A M Wolfs, Valéria Lima Passos, et al.
Pediatric Research|July 23, 2020
The bioavailability and maturing clearance of doxapram in preterm infantsRobert B Flint, Sinno H P Simons, Peter Andriessen, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|April 30, 2025
Stakeholder Perspectives on the Design of First-In-Human Trials for Artificial Amnion and Placenta Technology: A Qualitative StudyAngret de Boer, André Krom, Rania Kalaai, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|March 3, 2022
Two-year neurodevelopmental outcome in children born extremely preterm: the EPI-DAF studyPauline E van Beek, Monique Rijken, Lisa Broeders, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|December 10, 2023
Neurodevelopmental outcome at 5.5 years in Dutch preterm infants born at 24-26 weeks' gestational age: the EPI-DAF studyPauline E van Beek, Monique Rijken, Lisa Broeders, et al.
Plos One|October 17, 2012
A clinical prediction rule for histological chorioamnionitis in preterm newbornsJasper V Been, Sizzle F Vanterpool, Jasmijn D E de Rooij, et al.
Experimental Neurology|October 15, 2013
Systemic G-CSF attenuates cerebral inflammation and hypomyelination but does not reduce seizure burden in preterm sheep exposed to global hypoxia-ischemiaReint K Jellema, Valéria Lima Passos, Daan R M G Ophelders, et al.
Pageof 15